THE ALZHEIMER’S ASSOCIATION CLINICAL PRACTICE GUIDELINE FOR THE DIAGNOSTIC EVALUATION, TESTING, COUNSELING, AND DISCLOSURE OF SUSPECTED ALZHEIMER’S DISEASE AND RELATED DISORDERS (DETECD-ADRD): VALIDATED CLINICAL ASSESSMENT INSTRUMENTS

Banner Sun Health Research Institute, Banner Alzheimer’s Institute, Brigham and Women’s Hospital, Harvard Medical School, Massachusetts General Hospital, Emory University, University of Pennsylvania, Mayo Clinic, Tufts Medical Center, Cedars-Sinai

The guideline aims to provide a comprehensive framework for the diagnostic evaluation of Alzheimer’s disease and related disorders, emphasizing the importance of validated clinical assessment tools. It addresses the processes of testing, counseling, and disclosure to ensure effective patient management. The document is intended for healthcare professionals involved in the care of patients with cognitive impairments and aims to standardize practices across various clinical settings.